Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Gene expression data from bone marrow CD34+ cells of patients with myelodysplastic syndromes (MDS) and healthy controls
PubMed Full text in PMC Similar studies Analyze with GEO2R
Expression data from Tet2-hypomorph (knockdown) and/or Ezh2-null Lineage-Sca-1+c-Kit+ (LSK) cells and granulocyte-macrophage progenitors (GMPs)
ASXL1 Mutations Promote Myeloid Transformation Through Loss of PRC2-Mediated Gene Repression
PubMed Full text in PMC Similar studies SRA Run Selector
ASXL1 Knock Down in Normal CD34+ Cord Blood and UKE1 Cell Lines
Expression data from RUNX1S291fs-mutant and/or Ezh2 conditional knockout Lineage-c-Kit+Sca-1+ (LSK) cells
PubMed Similar studies Analyze with GEO2R
Mutant WT1 is Associated with DNA Hypermethylation of PRC2 Targets in AML and Responds to EZH2 Inhibition
PubMed Full text in PMC Similar studies
Gene expression Profiling in Follicular Lymphomas
Tetraspanin family member, CD82, regulates expression of EZH2 via inactivation of p38 MAPK signaling in leukemia cells. The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells.
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in myeloid malignancies [MDS_normal]
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in myeloid malignancies [AML_normal]
HOXB-AS3 expressions promote cell proliferation
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on